biotech · Atopic Dermatitis · Asthma · APGE
Apogee Therapeutics
Apogee Therapeutics is a biotech organization headquartered in WALTHAM, MA, USA. It trades on NYSE under ticker APGE. Primary therapeutic focus areas include Atopic Dermatitis, Asthma, Carcinoma, Hepatocellular, Diffuse
WALTHAM, MA, USA HQ
2022 Founded
293 Employees
Public company Type
APGE · NYSE Ticker
Company details
- Status
- Public
- HQ
- WALTHAM, MA, USA
- Founded
- 2022
- Employees
- 293
- Programs
- 8
- Drugs
- 2
- Patents
- 7
APG777
Phase 2 · small molecule · Atopic Dermatitis
APG777 for Atopic Dermatitis is a Phase 2 program (small_molecule) at Apogee Therapeutics with 3 ClinicalTrials.gov record(s).
Internal code APG777-202
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Apogee Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Atopic Dermatitis
- Status
- active
- Trials
- 3